Research Projects
Cancer immunotherapy has revolutionised the treatment of many cancers, but this potentially effective treatment can also cause significant side-...
Supervisor: Dr Miles Andrews
Lung cancer patient's die from metastatic disease, not primary disease. In the case of small cell lung cancer the brain is a primary site of...
Supervisor: A/Prof Daniel Gough
Osteosarcoma is the most prevalent primary bone tumour, with a predominance in children and adolescents in periods of rapid growth. Despite...
Supervisor: A/Prof Jason Cain
Epigenetics provides an interface between the environment and DNA function through the ability of epigenetic modifications to regulate gene...
Supervisor: Professor Patrick Western
Pattern recognition receptors, including Toll-like receptors (TLRs) and NOD-like receptors (NLRs), are key components of the innate immune response....
Supervisor: Associate Professor Kate Lawlor
The World Mosquito Program (WMP; based at Monash University) has pioneered a novel biocontrol tool, Wolbachia, that controls the transmission of...
Supervisor: Dr. Johanna Fraser
Antigen presentation is the fundamental and complex process in which a cell breaks down proteins into small fragments (peptides) and presents these...
Supervisor: Chen Li
Gastric cancer kills ~1 million people worldwide each year and has an average 5-year survival rate of 19%. It is, therefore, a cancer of unmet need....
Supervisor: Dr Dustin Flanagan
It is well-known that cancer treatments damage eggs in the ovary to impair fertility. However, the impacts of different cancer treatments on the...
Supervisor: Dr Amy Winship
Osteosarcoma is the most prevalent primary malignant tumour of the bone, mainly affecting teenagers and young adults, particularly during growth...
Supervisor: A/Prof Jason Cain
Pasteurella multocida is a Gram-negative bacterial pathogen that causes a number of different diseases in cattle,
pigs and poultry, resulting in...
Supervisor: Assoc Professor John Boyce
Our laboratory has for the first time identified a new NOD-like receptor (NLR) protein in the regulation of inflammation in response to chronic...
Supervisor: Professor Richard Ferrero
Brain tumours are highly immunosuppressed, which has meant that they are uniquely resistant to immunotherapies. Importantly, T cell infiltration into...
Supervisor: Leon Smyth
The mRNA therapeutics have emerged as a high potent new class of drug, revolutionizing disease treatments, such as therapeutic vaccines, monoclonal...
Supervisor: Nanoantibiotics - SHEN LAB
The ADNeT Registry a clinical quality registry (CQR) for people newly diagnosed with either dementia or mild cognitive impairment (MCI). The registry...
Supervisor: Dr Xiaoping Lin
Genome-wide association studies (GWAS) have been instrumental in discovering these loci, and they have successfully identified numerous disease-...
Supervisor: Dr Sathish Periyasamy
Antibiotic-resistance is a major problem in hospitals and different community settings. Dendritic cells are sentinel cells of the innate immune...
Supervisor: Assoc Professor Meredith O'Keeffe
The contraceptive pill has been linked to depressive mood. It has been hypothesised that the progesterone components of the pill are likely to drive...
Supervisor: Professor Jayashri Kulkarni
There are over 7,000 rare diseases that on average take ~4 years to diagnose, during which families consult on average 5 doctors and receive 3...
Supervisor: Professor Katrina Williams
Designing, analysing and interpreting evidence from interrupted time series studies in public health
The interrupted time series (ITS) study design is frequently used to evaluate the effects of policy and health systems interventions, providing...
Supervisor: Dr Joanne McKenzie